The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD).

Autor: Pisaniello HL; Discipline of Medicine, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia huaileng.pisaniello@adelaide.edu.au.; Basil Hetzel Institute for Translational Health Research, Woodville South, South Australia, Australia., Lester SE; Basil Hetzel Institute for Translational Health Research, Woodville South, South Australia, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia., Russell O; Discipline of Medicine, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia.; Basil Hetzel Institute for Translational Health Research, Woodville South, South Australia, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia., Black R; Basil Hetzel Institute for Translational Health Research, Woodville South, South Australia, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia., Tieu J; Basil Hetzel Institute for Translational Health Research, Woodville South, South Australia, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia., Richards B; Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Rheumatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Barrett C; Department of Rheumatology, Redcliffe Hospital, Redcliffe, Queensland, Australia.; Department of Medicine, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Lassere M; Department of Rheumatology, St George Hospital, Sydney, New South Wales, Australia.; Department of Medicine, University of New South Wales School of Population Health, Sydney, New South Wales, Australia., March L; Florence and Cope Professorial Department of Rheumatology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Institute of Bone and Joint Research at Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia., Buchbinder R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Hill C; Basil Hetzel Institute for Translational Health Research, Woodville South, South Australia, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia., Whittle SL; Basil Hetzel Institute for Translational Health Research, Woodville South, South Australia, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Sep 30; Vol. 83 (10), pp. 1400-1402. Date of Electronic Publication: 2024 Sep 30.

Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis.

Autor: Pisaniello HL; Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia. huaileng.pisaniello@adelaide.edu.au.; Rheumatology Research Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA, Australia. huaileng.pisaniello@adelaide.edu.au., Whittle SL; Rheumatology Research Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Woodville South, SA, Australia., Lester S; Rheumatology Research Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Woodville South, SA, Australia., Menz F; Flinders Medical Centre, Bedford Park, SA, Australia., Metcalf R; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, SA, Australia., McWilliams L; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, SA, Australia., Hill CL; Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Rheumatology Research Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA, Australia.; Rheumatology Unit, The Queen Elizabeth Hospital, Woodville South, SA, Australia.; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, SA, Australia., Proudman S; Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.

Publikováno v: BMC rheumatology [BMC Rheumatol] 2022 Nov 15; Vol. 6 (1), pp. 67. Date of Electronic Publication: 2022 Nov 15.

Heterogeneity in the association between weather and pain severity among patients with chronic pain: a Bayesian multilevel regression analysis.

Autor: Yimer BB; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom.; NIHR Greater Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom., Schultz DM; Department of Earth and Environmental Sciences, Centre for Atmospheric Science, University of Manchester, Manchester, United Kingdom.; Centre for Crisis Studies and Mitigation, University of Manchester, Manchester, United Kingdom., Beukenhorst AL; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Lunt M; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom.; NIHR Greater Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom., Pisaniello HL; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom.; Discipline of Medicine, The University of Adelaide, Adelaide, Australia., House T; School of Mathematics, The University of Manchester, Manchester, United Kingdom., Sergeant JC; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom.; Centre for Biostatistics, University of Manchester, Manchester, United Kingdom., McBeth J; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom.; NIHR Greater Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom., Dixon WG; Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, United Kingdom.; NIHR Greater Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.

Publikováno v: Pain reports [Pain Rep] 2022 Jan 12; Vol. 7 (1), pp. e963. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2022).

Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.

Autor: Tieu J; Rheumatology Research Group, Basil Hetzel Institute, Adelaide, Australia, Adelaide Medical School, University of Adelaide, Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, Rheumatology Unit, Lyell McEwin Hospital, Adelaide, Australia, Adelaide, Australia., Cheah JT; Division of Rheumatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA, Division of Rheumatology, UMass Memorial Health Care, Worcester, MA, USA., Black RJ; Rheumatology Research Group, Basil Hetzel Institute, Adelaide, Australia, Adelaide Medical School, University of Adelaide, Adelaide, Australia, Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia., Christensen R; Musculoskeletal Statistics Unit at The Parker Institute, Bispebjerg, Denmark, Frederiksberg Hospital, Copenhagen & Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark., Ghosh N; Division of Rheumatology, Hospital for Special Surgery, New York, USA., Richards P; Patient research partner., Robson J; Rheumatology Research, Centre for Health and Clinical Research, University of the West of England, Bristol, UK, Rheumatology Department, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Shea B; Bruyère Research Institute, Senior Methodologist, Ottawa Hospital Research Institute, Ottawa, Canada, Adjunct Professor, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada., Simon LS; SDG, LLC, Cambridge, MA, USA., Singhi JA; Medicine Service, VA Medical Center, 700 19th St S, Birmingham, AL 35233 USA, Department of Medicine at the School of Medicine, University of Alabama at Birmingham (UAB), 1720 Second Ave. South, Birmingham, AL 35294-0022, USA, Department of Epidemiology at the UAB School of Public Health, 1665 University Blvd., Ryals Public Health Building, Room 220, Birmingham, AL, 35294-0022, USA., Tugwell P; Division of Rheumatology, Department of Medicine, University of Ottawa, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Abbreviation., Boers M; Department of Epidemiology & Data Science, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands, Marco A Alba Garibay, Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, IRB-CELLEX, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain., Garibay MAA; Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, IRB-CELLEX, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain., Campochiaro C; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Decary S; Patient-Oriented Rehabilitation Lab (SPOR-REHAB), University of Sherbrooke, Faculty of Medicine and Health Sciences, School of Rehabilitation, Research Centre of the CHUS, CIUSSS de l'Estrie-CHUS, Canada., de Witt M; Patient research partner., Fernandez AP; Department of Dermatology & Department of Pathology Cleveland Clinic, Cleveland, OH, USA., Keen HI; School of Medicine, University of Western Australia, Perth, Australia, Rheumatology Department, Fiona Stanley Hospital, Perth, Australia., King L; Department of Medicine, University of Toronto, Canada., Hinojosa-Azaola A; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Hofstetter C; Patient research partner., Gaydukova I; North-Western State medical University named after II Mechnikov, Saint-Petersburg, Russia., George MD; University of Pennsylvania, Division of Rheumatology, Philadelphia, PA, USA., Gupta L; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow India., Lyne S; Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, College of Medicine and Public Health, Flinders University, Adelaide, South Australia., Makol A; Division of Rheumatology, Mayo Clinic, Rochester, MN, USA., Mukhtyar C; Rheumatologist, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK., Oo WM; Rheumatology department, Royal North Shore Hospital, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, University of Medicine, Mandalay, Mandalay, Myanmar., Petri M; Division of Rheumatology, Johns Hopkins University School of Medicine, USA., Pisaniello HL; Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, South Australia, Australia, Rheumatology Research Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia., Sattui SE; Division of Rheumatology, Hospital for Special Surgery, New York, USA., Russell O; Adelaide Medical School, The University of Adelaide, Adelaide, South Australia., Teixeira V; Serviço de Reumatologia, Hospital de Faro, Centro Hospitalar Universitário do Algarve, Portugal., Toupin-April K; School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Department of Pediatrics, Faculty of Medicine, University of Ottawa, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada., Uhunmwangho C; Department of Medicine, University of Jos, Nigeria., Whitstock M; Patient research partner., Yip K; Division of Rheumatology, Hospital for Special Surgery, New York, USA., Mackie SL; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Goodman SM; Division of Rheumatology, Hospital for Special Surgery, New York, USA, Weill Cornell Medical College, New York, USA., Hill CL; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, Rheumatology Research Group, Basil Hetzel Institute, Adelaide, Australia, Adelaide Medical School, University of Adelaide, Adelaide, Australia. Electronic address: catherine.hill@sa.gov.au.

Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2021 Oct; Vol. 51 (5), pp. 1139-1145. Date of Electronic Publication: 2021 Jun 25.

Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review.

Autor: Farquhar H; Department of Medicine, University of Otago, Christchurch, New Zealand., Vargas-Santos AB; Department of Internal Medicine, Rio de Janeiro State University, Rio de Janeiro, Brazil., Pisaniello HL; Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia., Fisher M; PrimaCare, Fall River, MA., Hill C; Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia., Gaffo AL; Division of Rheumatology and Clinical Immunology, University of Alabama, Birmingham.; Birmingham VA Medical Center, Birmingham, AL, USA., Stamp LK; Department of Medicine, University of Otago, Christchurch, New Zealand.

Publikováno v: Rheumatology advances in practice [Rheumatol Adv Pract] 2021 Jan 04; Vol. 5 (1), pp. rkaa073. Date of Electronic Publication: 2021 Jan 04 (Print Publication: 2021).